PET/CT

Positron emission tomography/computed tomography is a hybrid nuclear medicine imaging technique that helps radiologists spot abnormal metabolic activity. PET/CT is commonly used to diagnose cancers, heart diseases and certain brain disorders, among other conditions.

Drugmaker expands manufacturing of popular prostate PET imaging agent
The move will make the Huntsman Cancer Institute the first academic medical center in the U.S. to produce Posluma, according to Blue Earth Diagnostics.
FDA clears new PET/MRI combo system from Siemens Healthineers
The Biograph One is the company's second-generation PET/MRI combo scanner—its first in 14 years.
ASNC says PET is now the preferred nuclear imaging test for CAD
Which imaging modality is better for evaluating heart patients, PET or SPECT? After years of discussions and debates, the American Society of Nuclear Cardiology is now ready to point to PET as the No. 1 choice. “There are no clinical scenarios or patient subgroups where cardiac PET with myocardial blood flow should be excluded," the group wrote.
FAPI PET shows promise to make a big impact in cardiovascular imaging
More and more imaging researchers are starting to examine the potential of using fibroblast activation protein inhibitors (FAPI) to manage patients with suspected cardiovascular disease.
Software glitch prompts FDA recall of popular PET systems
The recall was issued due to the potential for the systems to produce artifacts during PET exams.

Drugmaker expands manufacturing of popular prostate PET imaging agent

The move will make the Huntsman Cancer Institute the first academic medical center in the U.S. to produce Posluma, according to Blue Earth Diagnostics.

FDA clears Siemens Healthineers' Biograph One PET/MR system

FDA clears new PET/MRI combo system from Siemens Healthineers

The Biograph One is the company's second-generation PET/MRI combo scanner—its first in 14 years.

Imagers reviewing flurpiridaz F-18 (Flyrcado) myocardial perfusion PET images. Image from GE Healthcare

ASNC says PET is now the preferred nuclear imaging test for CAD

Which imaging modality is better for evaluating heart patients, PET or SPECT? After years of discussions and debates, the American Society of Nuclear Cardiology is now ready to point to PET as the No. 1 choice. “There are no clinical scenarios or patient subgroups where cardiac PET with myocardial blood flow should be excluded," the group wrote.

SNMMI Image of the Year 68Ga-FAPI-46 PET/CT heart attack acute myocardial infarction

FAPI PET shows promise to make a big impact in cardiovascular imaging

More and more imaging researchers are starting to examine the potential of using fibroblast activation protein inhibitors (FAPI) to manage patients with suspected cardiovascular disease.

Software glitch prompts FDA recall of popular PET systems

The recall was issued due to the potential for the systems to produce artifacts during PET exams.

PET-CT imaging of 124-I evuzamitide and SPECT-CT imaging of 99mTc-p5+14 showed radiotracer uptake in both AL and ATTR amyloid throughout the myocardium. Emily B. Martin, Anne Kassira, Alan Stuckey, et al. A tale of two tracers - Amyloid imaging with investigational radiotracers iodine (124I) evuzamitide and 99mTc-p5+14 (AT-05). https://www.journalofnuclearcardiology.org/article/S1071-3581(25)00325-3/abstract.

Bayer expands into molecular imaging with cardiac amyloidosis tracer acquisitions

Bayer is acquiring two cardiac amyloidosis radiotracers from Attralus, one for PET and one for SPECT. The SPECT tracer is also a theranostic agent to both image and treat amyloidosis.

Sarah-Jane James, CT, MRI, molecular imaging senior market analyst for Signify Research, explains key trends in imaging systems she saw at the Radiological Society of North America (RSNA) 2025 meeting.

Key trends in medical imaging systems at RSNA 2025

Sarah-Jane James, imaging market analyst for Signify Research, discusses key trends in the specialty that she saw at the Radiological Society of North America's annual meeting.

Positron NeuSight PET-CT 64 slice scanner

Positron raises $2M to expand PET-CT commercialization

The New York-based imaging company is now focused on expanding sales for the cost-effective PET-CT system it developed with Neusoft Medical Systems.